Compare Adobe Systems Inc (ADBE) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adobe Systems Inc vs IDEXX Laboratories, Inc. — how do they compare? Adobe Systems Inc trades at $258.32 (market cap $104.82B), while IDEXX Laboratories, Inc. trades at $571 (market cap $46.22B). The key difference: Adobe Systems Inc is far larger — about 2.3× IDEXX Laboratories, Inc.'s market cap, and Adobe Systems Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| ADBE | IDXX | |
|---|---|---|
Market Cap | $104.82B | $46.22B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $367.46 | $766.68 |
52-Week Low | $193.41 | $526.44 |
Enterprise Value | $106.26B | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe Inc. (ADBE) trades at $263.71, down 3.39% on the day, with the stock showing mixed technical signals amid a bullish overall trend. Fundamentally, the company demonstrates strong profitability with a 28.69% net income margin and consistent earnings beats, though recent news highlights AI competition concerns. Revenue growth remains robust at $23.77 billion for 2025, while valuation metrics like a P/E of 15.09 appear reasonable relative to historical levels.
The outlook for ADBE is cautiously optimistic with solid fundamentals offset by near-term AI disruption fears. Investment opportunity lies in the company's strong cash flow generation and market leadership, while risks include competitive pressure from AI tools and CEO transition uncertainty. Analyst consensus remains favorable with 49.2% buy ratings, though the stock trades below the $248.86 consensus price target.
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
